DK0640098T3 - S-gen fra hundecoronavirus og anvendelser deraf - Google Patents
S-gen fra hundecoronavirus og anvendelser derafInfo
- Publication number
- DK0640098T3 DK0640098T3 DK93911346T DK93911346T DK0640098T3 DK 0640098 T3 DK0640098 T3 DK 0640098T3 DK 93911346 T DK93911346 T DK 93911346T DK 93911346 T DK93911346 T DK 93911346T DK 0640098 T3 DK0640098 T3 DK 0640098T3
- Authority
- DK
- Denmark
- Prior art keywords
- gene
- applications
- dog coronavirus
- ccv
- coronavirus
- Prior art date
Links
- 241000711573 Coronaviridae Species 0.000 title 1
- 101150010882 S gene Proteins 0.000 title 1
- 208000019698 Cutaneous collagenous vasculopathy Diseases 0.000 abstract 2
- 201000009911 cataract 8 multiple types Diseases 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88019492A | 1992-05-08 | 1992-05-08 | |
| PCT/US1993/004692 WO1993023423A1 (en) | 1992-05-08 | 1993-05-07 | Canine coronavirus s gene and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0640098T3 true DK0640098T3 (da) | 2002-10-28 |
Family
ID=25375695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93911346T DK0640098T3 (da) | 1992-05-08 | 1993-05-07 | S-gen fra hundecoronavirus og anvendelser deraf |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0640098B1 (da) |
| JP (1) | JP3245169B2 (da) |
| AT (1) | ATE225805T1 (da) |
| AU (1) | AU670092B2 (da) |
| CA (1) | CA2135200C (da) |
| DE (1) | DE69332375T2 (da) |
| DK (1) | DK0640098T3 (da) |
| ES (1) | ES2182827T3 (da) |
| PT (1) | PT640098E (da) |
| WO (1) | WO1993023423A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU678970B2 (en) * | 1992-05-08 | 1997-06-19 | Pfizer Inc. | Universal coronavirus vaccine |
| GB2282601B (en) * | 1993-09-16 | 1998-04-15 | Solvay | Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same |
| FR2828405B1 (fr) | 2001-08-09 | 2005-06-24 | Virbac Sa | Vaccin anti-coronavirus |
| GB0217434D0 (en) | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
| GB0315323D0 (en) | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
| US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| CN113583096B (zh) * | 2020-05-01 | 2023-06-30 | 清华大学 | SARS-CoV-2 Spike蛋白受体结合域二聚体及其应用 |
| CN112079906B (zh) * | 2020-07-15 | 2022-11-04 | 张影 | 一种新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒 |
| CN113945714B (zh) * | 2020-07-16 | 2023-01-31 | 南京蓬勃生物科技有限公司 | 新型冠状病毒中和抗体类药物中和能力的检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63123385A (ja) * | 1986-09-05 | 1988-05-27 | デュファル・インテルナチオナル・レセールフ・ベー・ヴェー | 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン |
| HUT45559A (en) * | 1987-01-16 | 1988-07-28 | Duphar Int Res | Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis |
| US4904468A (en) * | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
| CA2005291C (en) * | 1988-12-30 | 1999-01-26 | Beverly Dale | Feline infectious peritonitis virus diagnostic tools |
| ATE256746T1 (de) * | 1991-04-25 | 2004-01-15 | Akzo Nobel Nv | Subeinheits-impfstoff gegen hundecoronavirus |
| EP0524672A1 (en) * | 1991-06-27 | 1993-01-27 | Duphar International Research B.V | CCV vaccine |
| AU678970B2 (en) * | 1992-05-08 | 1997-06-19 | Pfizer Inc. | Universal coronavirus vaccine |
-
1993
- 1993-05-07 DE DE69332375T patent/DE69332375T2/de not_active Expired - Fee Related
- 1993-05-07 JP JP50381394A patent/JP3245169B2/ja not_active Expired - Fee Related
- 1993-05-07 PT PT93911346T patent/PT640098E/pt unknown
- 1993-05-07 AU AU42515/93A patent/AU670092B2/en not_active Ceased
- 1993-05-07 ES ES93911346T patent/ES2182827T3/es not_active Expired - Lifetime
- 1993-05-07 DK DK93911346T patent/DK0640098T3/da active
- 1993-05-07 WO PCT/US1993/004692 patent/WO1993023423A1/en active IP Right Grant
- 1993-05-07 AT AT93911346T patent/ATE225805T1/de not_active IP Right Cessation
- 1993-05-07 EP EP93911346A patent/EP0640098B1/en not_active Expired - Lifetime
- 1993-05-07 CA CA002135200A patent/CA2135200C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993023423A1 (en) | 1993-11-25 |
| ATE225805T1 (de) | 2002-10-15 |
| CA2135200A1 (en) | 1993-11-25 |
| DE69332375D1 (de) | 2002-11-14 |
| DE69332375T2 (de) | 2003-02-13 |
| AU670092B2 (en) | 1996-07-04 |
| EP0640098A1 (en) | 1995-03-01 |
| JPH07508421A (ja) | 1995-09-21 |
| CA2135200C (en) | 2001-03-27 |
| JP3245169B2 (ja) | 2002-01-07 |
| AU4251593A (en) | 1993-12-13 |
| EP0640098B1 (en) | 2002-10-09 |
| PT640098E (pt) | 2003-01-31 |
| EP0640098A4 (en) | 1997-01-02 |
| ES2182827T3 (es) | 2003-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL148079A0 (en) | Human ctla-4 antibodies and compositions containing the same | |
| SE0102315D0 (sv) | Compounds | |
| DE69124371D1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
| FI962247A (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät | |
| NO304884B1 (no) | 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav | |
| DE69314951D1 (de) | Dns sequenzierungsverfahren | |
| MY131388A (en) | Inhibitors of hiv protease useful for the treatment of aids. | |
| TR200200068T2 (tr) | Nematisital triflüorobütenler | |
| PL343495A1 (en) | Heterocyclically substituted amides used as calpain inhibitors | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| DE69725825D1 (de) | 5-HT1F-Agonisten | |
| SE9802729D0 (sv) | Novel Compounds | |
| DK0579681T3 (da) | Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse | |
| ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
| TR199902703T2 (xx) | Proteaz inhibit�rleri. | |
| DK0640098T3 (da) | S-gen fra hundecoronavirus og anvendelser deraf | |
| BR9609871A (pt) | Vacina de urease recombinante multimérica | |
| EP0387802A3 (en) | 5-substituted-1,4-dihydro-4-oxonaphthyridine-3-carboxylate antibacterial agents | |
| DE69808475T2 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| ID25478A (id) | Agonis 5-ht1f | |
| PL336897A1 (en) | Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts | |
| ATE420852T1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen | |
| BR0011889A (pt) | Cepa bacteriana, plasmìdio, processo de preparação de uma cepa bacteriana e de exopolissacarìdeo bacteriano e ácido nucleico | |
| DE3777359D1 (de) | Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns. |